share_log

希瑪眼科(03309.HK)進一步收購愛康健註冊資本7% 持股比例將擴大至61.5%

Sima Ophthalmology (03309.HK) further acquires Aikangjian registered Capital 7% stake will be expanded to 61.5%

即市頭條 ·  Nov 25, 2021 09:16

03309.HK announced an amendment to Shenzhen Aikangjian's investment terms, and Sima China agreed to buy a further 7 per cent of Shenzhen Aikangjian's total registered capital from Shenzhen Capital for 45.5 million yuan (the same below).

The Group also announced that it entered into a supplementary equity investment agreement with the original seller yesterday (24). However, the percentage of equity acquired by the Group and the total consideration payable remained unchanged.

Upon completion, the group will directly and indirectly hold a total of 61.5% of the enlarged issued shares of Shenzhen Aikangjian, and will be its controlling shareholder.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment